Clinical Laserthermia Systems AB (publ) (CLS-B) - Total Assets

Latest as of December 2025: Skr76.49 Million SEK ≈ $8.23 Million USD

Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) holds total assets worth Skr76.49 Million SEK (≈ $8.23 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See CLS-B book value for net asset value and shareholders' equity analysis.

Clinical Laserthermia Systems AB (publ) - Total Assets Trend (2008–2025)

This chart illustrates how Clinical Laserthermia Systems AB (publ)'s total assets have evolved over time, based on quarterly financial data.

Clinical Laserthermia Systems AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2025)

Clinical Laserthermia Systems AB (publ)'s total assets of Skr76.49 Million consist of 51.2% current assets and 48.9% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr0.00	28.2%
Accounts Receivable	Skr4.88 Million	6.4%
Inventory	Skr12.70 Million	16.6%
Property, Plant & Equipment	Skr0.00	0.0%
Intangible Assets	Skr11.29 Million	14.8%
Goodwill	Skr0.00	0.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Clinical Laserthermia Systems AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CLS-B company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Clinical Laserthermia Systems AB (publ)'s current assets represent 51.2% of total assets in 2025, an increase from 40.4% in 2008.
Cash Position: Cash and equivalents constituted 28.2% of total assets in 2025, down from 36.1% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, a decrease from 56.0% in 2008.
Asset Diversification: The largest asset category is inventory at 16.6% of total assets.

Clinical Laserthermia Systems AB (publ) Competitors by Total Assets

Key competitors of Clinical Laserthermia Systems AB (publ) based on total assets are shown below.

Company	Country	Total Assets
Demant A/S CO:DEMANT	Denmark	Dkr39.07 Billion
Double Medical Technology Inc SHE:002901	China	CN¥4.55 Billion
Beijing Wandong Medical Technology Co Ltd SHG:600055	China	CN¥5.70 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
MODULIGHT OY EO 1 F:78W	Germany	€49.14 Million
Diagnostic Medical Systems SA PA:ALDMS	France	€57.17 Million
Theradiag SA PA:ALTHE	France	€11.55 Million
Nova EYE Medical Ltd AU:EYE	Australia	AU$23.67 Million

Clinical Laserthermia Systems AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.91	2.99	0.56
Quick Ratio	2.64	2.35	0.50
Cash Ratio	0.00	0.00	0.00
Working Capital	Skr29.12 Million	Skr25.54 Million	Skr-19.41 Million

Clinical Laserthermia Systems AB (publ) - Advanced Valuation Insights

This section examines the relationship between Clinical Laserthermia Systems AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.46
Latest Market Cap to Assets Ratio	0.15
Asset Growth Rate (YoY)	-2.6%
Total Assets	Skr76.49 Million
Market Capitalization	$11.57 Million USD

Valuation Analysis

Below Book Valuation: The market values Clinical Laserthermia Systems AB (publ)'s assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Clinical Laserthermia Systems AB (publ)'s assets decreased by 2.6% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Clinical Laserthermia Systems AB (publ) (2008–2025)

The table below shows the annual total assets of Clinical Laserthermia Systems AB (publ) from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	Skr76.49 Million ≈ $8.23 Million	-2.64%
2024-12-31	Skr78.56 Million ≈ $8.45 Million	+36.10%
2023-12-31	Skr57.73 Million ≈ $6.21 Million	+16.60%
2022-12-31	Skr49.51 Million ≈ $5.33 Million	-25.82%
2021-12-31	Skr66.74 Million ≈ $7.18 Million	+50.31%
2020-12-31	Skr44.40 Million ≈ $4.78 Million	+14.82%
2019-12-31	Skr38.67 Million ≈ $4.16 Million	-33.36%
2018-12-31	Skr58.02 Million ≈ $6.24 Million	+29.11%
2017-12-31	Skr44.94 Million ≈ $4.84 Million	+64.59%
2016-12-31	Skr27.30 Million ≈ $2.94 Million	+22.62%
2015-12-31	Skr22.27 Million ≈ $2.40 Million	-39.74%
2014-12-31	Skr36.95 Million ≈ $3.98 Million	+26.56%
2013-12-31	Skr29.20 Million ≈ $3.14 Million	+45.54%
2012-12-31	Skr20.06 Million ≈ $2.16 Million	+54.26%
2011-12-31	Skr13.01 Million ≈ $1.40 Million	+10.56%
2010-12-31	Skr11.76 Million ≈ $1.27 Million	+43.41%
2009-12-31	Skr8.20 Million ≈ $882.69K	+48.50%
2008-12-31	Skr5.52 Million ≈ $594.40K	--

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices

Market Cap

$11.57 Million

Skr107.52 Million SEK

Market Cap Rank

#26505 Global

#570 in Sweden

Share Price

Skr3.45

Change (1 day)

-4.83%

52-Week Range

Skr2.62 - Skr11.82

All Time High

Skr1089.26